Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24014601 | 0.90 | FUCA1 (0.32) | FUCA1 | |
| SCHEMBL25757863 | 0.90 | FUCA1 (0.32) | FUCA1 | |
| SCHEMBL25229868 | 0.79 | CTSV (0.32) | — | |
| SCHEMBL25276290 | 0.79 | CTSV (0.32) | — | |
| SCHEMBL24015175 | 0.78 | FUCA1 (0.34) | KDM1AFUCA1 | |
| SCHEMBL30489479 | 0.77 | — | — | |
| SCHEMBL25277914 | 0.75 | KMT2A (0.38) | — | |
| SCHEMBL24015169 | 0.75 | — | — | |
| SCHEMBL25758125 | 0.74 | — | — | |
| SCHEMBL25758173 | 0.73 | CTSV (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192660-A1 | Protease Inhibitors for Treatment or Prevention of Coronavirus Disease | UNIV LELAND STANFORD JUNIOR (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230192660-A1 | Protease Inhibitors for Treatment or Prevention of Coronavirus Disease | UNIV LELAND STANFORD JUNIOR (US) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192660-A1 | Protease Inhibitors for Treatment or Prevention of Coronavirus Disease | ACE, ACE2, PEPD | KDM1A 1668/4885FUCA1 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.